Financials Zevia PBC

Equities

ZVIA

US98955K1043

Non-Alcoholic Beverages

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
0.8517 USD +3.44% Intraday chart for Zevia PBC -10.35% -57.63%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 242.9 183.5 101.3 49.55 - -
Enterprise Value (EV) 1 169.8 136.1 69.36 14.62 19.91 17.74
P/E ratio -5.3 x -5.05 x -4.9 x -2.37 x -2.43 x -2.66 x
Yield - - - - - -
Capitalization / Revenue 1.76 x 1.12 x 0.61 x 0.31 x 0.28 x 0.25 x
EV / Revenue 1.23 x 0.83 x 0.42 x 0.09 x 0.11 x 0.09 x
EV / EBITDA -19.5 x -6.93 x -3.64 x -1.06 x -2.25 x -3.9 x
EV / FCF -3.33 x -5.82 x -3.88 x -0.73 x -1.25 x -
FCF Yield -30% -17.2% -25.8% -138% -80.1% -
Price to Book 1.65 x 1.62 x 1.13 x 0.82 x 1.03 x 0.91 x
Nbr of stocks (in thousands) 34,456 44,866 50,408 58,181 - -
Reference price 2 7.050 4.090 2.010 0.8517 0.8517 0.8517
Announcement Date 2/24/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 138.2 163.2 166.4 162.3 177.3 195.3
EBITDA 1 - -8.705 -19.64 -19.05 -13.85 -8.845 -4.544
EBIT 1 - -87.43 -47.87 -28.94 -23.72 -20.01 -6.866
Operating Margin - -63.27% -29.33% -17.39% -14.62% -11.29% -3.52%
Earnings before Tax (EBT) 1 - -87.63 -47.58 -28.27 -23.15 -20.82 -6.866
Net income 1 -6.071 -45.99 -33.86 -21.49 -21.52 -16.31 -6.866
Net margin - -33.28% -20.75% -12.92% -13.26% -9.2% -3.52%
EPS 2 -28.05 -1.330 -0.8100 -0.4100 -0.3600 -0.3500 -0.3200
Free Cash Flow 1 - -50.95 -23.37 -17.9 -20.15 -15.95 -
FCF margin - -36.87% -14.32% -10.75% -12.42% -8.99% -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 4/19/21 2/24/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 34.17 38.03 45.54 44.24 35.37 43.3 42.24 43.09 37.79 38.8 38.92 44.26 39.84 43.7 42.9
EBITDA 1 -5.261 -8.303 -6.372 -2.058 -2.908 -0.452 -2.615 -9.133 -6.849 -5.466 -3.546 -2.961 -1.808 -2.867 -1
EBIT 1 -37.46 -17.56 -14.74 -9.221 -6.349 -3.251 -5.377 -11.42 -8.895 -7.283 -6.125 -5.762 -4.435 -6.511 -5.05
Operating Margin -109.64% -46.16% -32.37% -20.84% -17.95% -7.51% -12.73% -26.5% -23.54% -18.77% -15.74% -13.02% -11.13% -14.9% -11.77%
Earnings before Tax (EBT) 1 -37.42 -17.47 -14.79 -9.195 -6.127 -2.911 -4.974 -11.26 -9.13 -7.186 -5.967 -6.133 -4.8 -7.4 -5.05
Net income 1 -20.16 -10.9 -11.09 -7.484 -4.385 -2.091 -3.931 -8.217 -7.255 -5.824 -6.125 -5.45 -3.9 -6.4 -4.05
Net margin -59.01% -28.65% -24.35% -16.92% -12.4% -4.83% -9.31% -19.07% -19.2% -15.01% -15.74% -12.31% -9.79% -14.65% -9.44%
EPS 2 -0.5900 -0.3000 -0.2800 -0.1700 -0.1000 -0.0300 -0.0800 -0.1600 -0.1400 -0.1000 -0.0967 -0.0883 -0.0750 -0.0975 -0.0833
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 2/24/22 5/12/22 8/11/22 11/10/22 2/28/23 5/9/23 8/8/23 11/7/23 2/27/24 5/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 73.1 47.4 32 34.9 29.6 31.8
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -50.9 -23.4 -17.9 -20.2 -16 -
ROE (net income / shareholders' equity) - -125% -30.2% -21.5% -19.5% -17.9% -9.56%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 4.270 2.530 1.780 1.040 0.8300 0.9400
Cash Flow per Share - -0.5200 -0.5000 - - - -
Capex 1 - 33.1 2.59 1.62 12 12 -
Capex / Sales - 23.99% 1.59% 0.98% 7.4% 6.77% -
Announcement Date 4/19/21 2/24/22 2/28/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
0.8517 USD
Average target price
2.307 USD
Spread / Average Target
+170.89%
Consensus